We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (AMD3100)

This study has been withdrawn prior to enrollment.
(Never Activated)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01353937
First Posted: May 16, 2011
Last Update Posted: March 4, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institutes of Health (NIH)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
New York University School of Medicine
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)